DIL is currently trading at Rs. 1097.35, up by 52.25 points or 5.00% from its previous closing of Rs. 1045.10 on the BSE.
The scrip opened at Rs. 1097.35 and has touched a high and low of Rs. 1097.35 and Rs. 1097.35 respectively. So far 940 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 1097.35 on 13-Oct-2017 and a 52 week low of Rs. 590.00 on 04-Sep-2017.
Last one week high and low of the scrip stood at Rs. 1097.35 and Rs. 812.10 respectively. The current market cap of the company is Rs. 251.64 crore.
The promoters holding in the company stood at 62.59%, while Institutions and Non-Institutions held 0.01% and 37.40% respectively.
DIL has received an approval to sign a Term Sheet to acquire 3,830,072 equity shares in its subsidiary, Fermenta Biotech (FBL), representing 21.05% of the issued and paid-up capital of FBL, from Evolvence India Life Sciences Fund LLC, a Private Equity Investor. The Board of Directors of the company at its meeting held on October 11, 2017 have authorised the same.
DIL (earlier known as Duphar-Interfran) is a well-respected public listed company. It has built a stellar reputation for itself in the arenas of pharmaceuticals, biotechnology, environmental solutions and other segments including Entertainment and Health & Wellness.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1804.50 |
Dr. Reddys Lab | 1201.45 |
Cipla | 1551.30 |
Lupin | 2104.90 |
Zydus Lifesciences | 879.85 |
View more.. |